A.-M. Dingemans

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Sungkyunkwan University(Current)

Amgen (United States)

Dana-Farber Cancer Institute

A.-M. Dingemans is an author at Sungkyunkwan University specializing in small cell lung cancer therapy, targeted cancer therapy, and combination chemotherapy.

Publications per year

2024–2024

Publications

OA10.03 Tarlatamab Sustained Clinical Benefit and Safety in Previously Treated SCLC: DeLLphi-301 Phase 2 Extended Follow-up

J. Sands, B.C. Cho, M.-J. Ahn et al. · Journal of Thoracic Oncology · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +4

P1.13A.02 Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial

M. Pérol, M.-J. Ahn, Yun Cheng et al. · Journal of Thoracic Oncology · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2